307 related articles for article (PubMed ID: 18662968)
1. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?
Caligaris-Cappio F; Ghia P
J Clin Oncol; 2008 Sep; 26(27):4497-503. PubMed ID: 18662968
[TBL] [Abstract][Full Text] [Related]
2. New insights into the pathogenesis of chronic lymphocytic leukemia.
Klein U; Dalla-Favera R
Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
[TBL] [Abstract][Full Text] [Related]
3. From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity.
Ghia P; Scielzo C; Frenquelli M; Muzio M; Caligaris-Cappio F
Autoimmun Rev; 2007 Dec; 7(2):127-31. PubMed ID: 18035322
[TBL] [Abstract][Full Text] [Related]
4. The origin of B-cell chronic lymphocytic leukemia.
Ghia P; Caligaris-Cappio F
Semin Oncol; 2006 Apr; 33(2):150-6. PubMed ID: 16616061
[TBL] [Abstract][Full Text] [Related]
5. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.
Calin GA; Croce CM
Semin Oncol; 2006 Apr; 33(2):167-73. PubMed ID: 16616063
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in the pathogeny of chronic lymphocytic leukaemia.
Nicoloso MS; Kipps TJ; Croce CM; Calin GA
Br J Haematol; 2007 Dec; 139(5):709-16. PubMed ID: 18021085
[TBL] [Abstract][Full Text] [Related]
7. What is the current evidence for antigen involvement in the development of chronic lymphocytic leukemia?
Tobin G; Rosén A; Rosenquist R
Hematol Oncol; 2006 Mar; 24(1):7-13. PubMed ID: 16315334
[TBL] [Abstract][Full Text] [Related]
8. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation.
Ghia P; Chiorazzi N; Stamatopoulos K
J Intern Med; 2008 Dec; 264(6):549-62. PubMed ID: 19017179
[TBL] [Abstract][Full Text] [Related]
9. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
[TBL] [Abstract][Full Text] [Related]
10. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
[TBL] [Abstract][Full Text] [Related]
11. IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors.
Belessi CJ; Davi FB; Stamatopoulos KE; Degano M; Andreou TM; Moreno C; Merle-Béral H; Crespo M; Laoutaris NP; Montserrat E; Caligaris-Cappio F; Anagnostopoulos AZ; Ghia P
Eur J Immunol; 2006 Jul; 36(7):1963-74. PubMed ID: 16783849
[TBL] [Abstract][Full Text] [Related]
12. Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors.
Chiotoglou I; Smilevska T; Samara M; Likousi S; Belessi C; Athanasiadou I; Stavroyianni N; Samara S; Laoutaris N; Vamvakopoulos N; Anagnostopoulos A; Fassas A; Stamatopoulos K; Kollia P
Blood Cells Mol Dis; 2008; 41(2):203-9. PubMed ID: 18621559
[TBL] [Abstract][Full Text] [Related]
13. B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens.
Chiorazzi N; Hatzi K; Albesiano E
Ann N Y Acad Sci; 2005 Dec; 1062():1-12. PubMed ID: 16461783
[TBL] [Abstract][Full Text] [Related]
14. The normal counterpart to the chronic lymphocytic leukemia B cell.
Caligaris-Cappio F; Ghia P
Best Pract Res Clin Haematol; 2007 Sep; 20(3):385-97. PubMed ID: 17707828
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.
Nana-Sinkam SP; Croce CM
Cancer Genet Cytogenet; 2010 Dec; 203(2):127-33. PubMed ID: 21156224
[TBL] [Abstract][Full Text] [Related]
16. The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.
Rawstron AC; Bennett F; Hillmen P
Br J Haematol; 2007 Dec; 139(5):724-9. PubMed ID: 18021087
[TBL] [Abstract][Full Text] [Related]
17. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
[TBL] [Abstract][Full Text] [Related]
18. Role of the B-cell receptor in chronic lymphocytic leukemia: where do we stand?
Fais F; Bruno S; Ghiotto F
Ital J Anat Embryol; 2010; 115(1-2):79-84. PubMed ID: 21072994
[TBL] [Abstract][Full Text] [Related]
19. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
[TBL] [Abstract][Full Text] [Related]
20. Antigens in chronic lymphocytic leukemia--implications for cell origin and leukemogenesis.
Rosén A; Murray F; Evaldsson C; Rosenquist R
Semin Cancer Biol; 2010 Dec; 20(6):400-9. PubMed ID: 20863893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]